Chapter 2. Analytical Methodology of Ginsenosides: Their Health Benefits, Anticancer and Antidementia Activities: A Review

Chong-Zhi Wang¹, Samantha Anderson¹, Tomoe Ohta², Takuhiro Uto², I. Jung Lee³, Hiroyuki Tanaka⁴, Tung Nguyen Huu⁵, Chun-Su Yuan¹,⁶ and Yukihiro Shoyama²
¹Tang Center for Herbal Medicine Research, and Departments of Anesthesia & Critical Care, University of Chicago, Chicago, IL, USA
²Faculty of Pharmacy, Nagasaki International University, Huis Tenbosh, Sasebo, Nagasaki, Japan
³Yokohama University of Pharmacy, Matano-cho, Totsuka-ku, Yokohama, Kanagawa, Japan
⁴Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, Sanyo-Onoda, Yamaguchi, Yamaguchi, Japan
⁵Faculty of Medicine, Phenikaa University, Hanoi, Vietnam
⁶Committee on Clinical Pharmacology and Pharmacogenomics, The Pritzker School of Medicine, University of Chicago, Chicago, Illinois, USA

Part of the book: Advances in Health and Disease. Volume 63


Panax ginseng, P. quinquefolius, and P. notoginseng including white ginseng and red ginseng prepared by air-drying and steaming or heating, respectively, are widely used herbal medicines. Quality control is necessary to ensure their consistency. Therefore, many analytical methodologies have been developed to assess quality, focusing mainly on high-performance liquid chromatography (HPLC). However, monoclonal antibodies (MAbs) against ginsenosides such as ginsenoside Rb1, Rg1, and Re and notoginsenoside R1 have been applied in recently developed techniques like Eastern blotting, one-step separation methods, and knockout extract preparations from ginseng. The anticancer activity of red ginseng is higher than that of white ginseng due to the production of active anticancer ginsenosides during the steaming process, resulting in apoptosis/paraptosisinduction and angiogenesis inhibition. Future studies should focus on characterizing active red ginseng derivatives as potential anticancer drugs. Additionally, the cognitive benefits of major ginsenosides and their mechanisms have been widely confirmed. Clinical trials of ginseng as a treatment for Alzheimer’s patients support its beneficial activity without side effects, demonstrating that ginseng might be a promising medicine for Alzheimer’s disease.

Keywords: Panax species, processed ginseng, monoclonal antibody, cancer chemoprevention, anti-dementia activity


Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;
286 (2): 208-216.
Attele AS, Wu JA and Yuan CS. Ginseng pharmacology: multiple constituents and multiple
actions. Biochem Pharmacol. 1999; 58(11): 1685-1693.
Aung HH, Mehendale SR, Wang CZ, Xie JT, McEntee E. Cisplatin’s tumoricidal effect on
human breast carcinoma MCF-7 cells was not attenuated by American ginseng.
Cancer Chemother Pharmacol. 2007; 59(3): 369-374.
Bae J, Koo J, Kim S, Park TY, Kim MY. Ginsenoside Rp1 Exerts Anti-inflammatory
Effects via Activation of Dendritic Cells and Regulatory T Cells. J Ginseng Res. 2012;
36(4): 375-382.
Baeg IH and So SH. The world ginseng market and the ginseng (Korea). J Ginseng Res.
2013; 37(1): 1-7.
Barnes PM, Bloom B and Nahin RL. Complementary and alternative medicine use among
adults and children: United States, 2007. Natl Health Stat Report. 2008; 12(12): 1-23.
Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative
medicine use among adults: United States, 2002. Adv Data. 2004; 343(343): 1-19.
Bosset JF, Collette L, Calais G. Chemotherapy with preoperative radiotherapy in rectal
cancer. N Engl J Med. 2006; 355(11): 1114-1123.
Breemen RBV, Huang CR, Lu ZZ, Remando A, Fong HHS and Fitzloff JF. 1995.
Electrospray liquid chromatography/mass spectrometry of ginsenosides. Anal Chem.
vol. 67: 3985-3989.
Chan TWD, But PPH, Chen SW, Kwok IMY, Lau FW, Xu HX. Differentiation and
authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using
HPLC/MS. Anal Chem. 2000; 72: 1281-1287.
Chao Z, Shoyama Y, Tanaka H. Pharmacokinetic study of ginsenosides Rb1 and Rg1 in rat
by ELISA using anti-ginsenosides Rb1 and Rg1 monoclonal antibodies. J Am Chin
Med. 2006; 34(6):1069–1081.
Chen YH, Lin YN, Chen WC, Hsieh WT, Chen HY. Treatment of stresses, Kim HP, Kim
J. urinary incontinence by ginsenoside Rh2. Am J Chin Med. 2014; 42(4): 817-831.sung
Chen, J., Zhang, X., Liu, X., Zhang, C., Shang, W., Xue J, Chen R, Xing Y, Song D, Xu R.
(2019a). Ginsenoside Rg1 Promotes Cerebral Angiogenesis via the PI3K/Akt/mTOR
Signaling Pathway in Ischemic Mice. Eur. J. Pharmacol. 856; 172418.
DOI: 10.1016/j.ejphar.2019.172418.
Cheong JH, Kim H, Hong MJ, Yang M, Kim JW, Yoo H, Yang H, Park JH, Sung S, Kim
HP, Kim J. Stereoisomer-specific anticancer activities of ginsenoside Rg3 and Rh2 in
HepG2 cells: disparity in cytotoxicity and autophagy-inducing effects due to 20(S)-
epimers. Biol Pharm Bull. 2015; 38(1): 102-108.
Choi S, Kim TW, Singh SV. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in
human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition
of cyclin-dependent kinases. Pharm Res. 2009; 26(10): 2280-2288.
Chu SF, Zhang Z, Zhou X, He WB, Chen C, Luo P, Liu DD, Ai QD, Gong HF, Wang ZZ,
Sun HS, Feng ZP, Chen NH. Ginsenoside Rg1 Protects against Ischemic/reperfusion Induced
Neuronal Injury through miR-144/Nrf2/ARE Pathway. Acta Pharmacol. Sin.
2019; 40: 13–25. DOI: 10.1038/s41401-018-0154-z.
Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein
family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014; 15(1): 49-63.
Elizabeth R, Tor MS, Filigenzi BP. Determination of oleandrin in tissues and biological
fluids by liquid chromatography-electrospray tandem mass spectrometry. J Agric
Food Chem. 2005; 53(11): 4322–4325.
Fishbein AB, Wang CZ, Li XL, Mehendale SR, Sun Shi, Aung HH, Yuan CS. Asian
ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal
cancer: comparison between white and red ginseng. Arch Pharm Res. 2009; 32(4): 505-513.
Folkman J. Angiogenesis: an organizing principle for drug discovery.
Nat Rev Drug Discov. 2007; 6(4): 273-286.
Fukuda N, Tanaka H and Shoyama Y. Applications of ELISA, Western blotting and
immunoaffinity concentration for survey of ginsenosides in crude drugs of Panax
species and traditional Chinese herbal medicines. Analyst 2000; 125: 1425-1429.
Fukuda N, Tanaka H, Shoyama Y. Double staining of ginsenosides by western blotting
using anti-ginsenoside Rb1 and Rg1 monoclonal antibodies. Biol Pharm Bull. 2001;
24(10): 1157–1160.
Fukuda N, Tanaka H, Shoyama Y. Formation of monoclonal antibody against a major
ginseng component, ginsenoside Rg1 and its characterization. Cytotechnology. 2000b;
34(3): 197–204.
Fukuda N, Tanaka H, Shoyama Y. Isolation of the pharmacologically active saponin
ginsenoside Rb1 from ginseng by immunoaffinity column chromatography. J Nat
Prod. 2000a; 63(2): 283–285.
Fukuda N, Tanaka H, Shoyama Y. Western blotting for ginseng saponins, ginsenosides
using anti-ginsenoside Rb1 monoclonal antibody. Biol Pharm Bull. 1999; 22(2): 219–220.
Gao J, Bai P, Li Y, Li J, Jia C, Wang T, Zhao H, Si Y, Chen J. Metabolomic Profiling of
the Synergistic Effects of Ginsenoside Rg1 in Combination with Neural Stem Cell
Transplantation in Ischemic Stroke Rats. J. Proteome Res. 2020; 19: 2676–2688.
DOI: 10.1021/acs.jproteome.9b00639.
Gao JL, Lv GY, He BC, Zhang Bq, Zhang H, Wang N, Wang CZ, Du W, Yuan CS, He TC.
Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting
multiple cancer signaling pathways. Oncol Rep. 2013; 30(1): 292-298.
Gao XQ, Yang C X, Chen G J, Wang GY, Chen B, Tan SK, Liu J, Yua QL. Ginsenoside
Rb1 Regulates the Expressions of Brain-Derived Neurotrophic Factor and Caspase-3
and Induces Neurogenesis in Rats with Experimental Cerebral Ischemia. J.
Ethnopharmacol. 2010; 132: 393–399. DOI: 10.1016/j.jep.2010. 07.033.
Garriques SS. On panaquilon, a new vegetable substance. Ann Chem Pharm. 1854; 90:
231–234. DOI: 10.1002/jlac.18540900216.
Gu C, Qiao J, Zhu M, Du J, Shang W, Yin W, Wang W, Han M, Lu W. Preliminary
evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-
fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells. Am J
Chin Med. 2013; 41(2): 443-458.
Guo Y, Wang LP, Li C, Xiong YX, Yan YT, Zhao LQ, Li SD, Sun J, Kuo HY,
Xian CJ. Effects of Ginsenoside Rb1 on Expressions of Phosphorylation
Akt/Phosphorylation mTOR/Phosphorylation PTEN in Artificial Abnormal
Hippocampal Microenvironment in Rats. Neurochem. Res. 2018; 43: 1927–1937.
DOI: 10.1007/s11064-018-2612-x.
Guo Z, Peng B, Li ZY and Pan RL. Study on transformation rule of saikosaponin a and
saikosaponin d under different extraction conditions by UPLC-QT tof-MS. Nat Prod
Res Dev. 2014; 26(5): 716–720.
Han JY, Hwang HS, Choi SW, Kim HJ, Choi YE. Cytochrome P450 CYP716A53v2
catalyzes the formation of protopanaxatriol from protopanaxadiol during ginsenoside
biosynthesis in Panax ginseng. Plant Cell Physiol. 2012; 53(9): 1535–1545.
Han JY, Kim HJ, Kwon YS, Choi YE. The Cyt P450 enzyme CYP716A47 catalyzes the
formation of protopanaxadiol from dammarenediol-II during ginsenoside biosynthesis
in Panax ginseng. Plant Cell Physiol. 2011; 52(12): 2067–2073.
Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in
commercial ginseng products: an analysis of 25 preparations.
Am J Clinical Nator. 2001; 73: 1101-1106.
Heo JH, Lee ST, Chu K, Oh MJ, Park HJ, Shim JY, Kim M. Heat-processed ginseng
enhances the cognitive function in patients with moderately severe Alzhaimer’s
disease. Nutr Neurosci. 2012; 15: 278-282. DOI: 10.1179/1476830512y.0000000027.
Heo JH, Lee ST, Oh MJ, Park HJ, Shim JY, Chu K. Kim M. Improvement of cognitive
deficit in Alzheimer’s disease patients’ long term treatment with Korean red ginseng.
J Ginseng Res. 2011; 35: 457-461. DOI: 10.5142/jgr.2011.35.4.457.
Hoa N, Myers MP, Douglass TG, Zhang JG, Delgado C, Driggers L, Callahan LL,
VanDeusen G, Pham JTH, Bhakta N, Ge L, Jadus MR. Molecular mechanisms of
paraptosis induction: implications for a non-genetically modified tumor vaccine.
PLoS One 2009; 4(2): e4631.
Hoffmann T, Krug D, Hüttel S and Müller R. Improving natural products identification
through targeted LC-MS/MS in an untargeted secondary metabolomics work flow.
Anal Chem. 2014; 86(21): 10780–10788.
Hsu YC, Chang PJ, Tung CW, Shih YH, Ni WC, Li YC, Uto T, Shoyama Y, Ho C, Lin
CL. De-glycyrrhizinated licorice extract attenuates high glucose-stimulated renal
tubular epithelial-mesenchymal transition via suppressing the Notch2 signaling
pathway. Cells. 2020;9(1):125.
Huang Q, Lou T, Wang M, Xue L, Lu J, Zhang H, Zhang Z, Wang H, Jing C, Zhao D, Sun
L, Li X. Compound K Inhibits Autophagy-Mediated Apoptosis Induced by Oxygen
and Glucose Deprivation/reperfusion via Regulating AMPK-mTOR Pathway in
Neurons. Life Sci. 2020; 254: 117793. DOI: 10.1016/j.lfs.2020.117793.
Huang Q, Su H, Qi B, Wang Y, Yan K, Wang X, Li X, Zhao D. A SIRT1 Activator,
Ginsenoside Rc, Promotes Energy Metabolism in Cardiomyocytes and Neurons A
SIRT1 Activator, Ginsenoside Rc, Promotes Energy Metabolism in Cardiomyocytes
and Neurons. J Am Chem Soc. 2021; 143: 1416–1427.
Itoh T, Zang YF, Murai S, Saito, H. Effects of Panax Ginseng Root on the Vertical and
Horizontal Motor Activities and on Brain Monoamine-Related Substances in Mice.
Planta Med. 1989; 55: 429–433. DOI: 10.1055/s-2006-96205.
Jia J. Efficacy and safety of the compound Chinese medicine SaiLuoTong in vascular
dementia: A randomized clinical trial. Alzheimer’s Dementia. 2018; 4: 108-117.
Jin YH, Yim H, Park JH Lee SK. Cdk2 activity is associated with depolarization of
mitochondrial membrane potential during apoptosis. Biochem Biophys Res Commun.
2003; 305(4): 974-980.
Joo EJ, Ha YW, Shin H, Son SH, Kim YS. Generation and characterization of monoclonal
antibody to ginsenoside Rg3. Biol Pharm Bull. 2009; 32(4): 548–552.
Ke L, Guo W, Xu J, Zhang G, Wang W, Huang W. Ginsenoside Rb1 Attenuates Activated
Microglia-Induced Neuronal Damage. Neural Regen. Res. 2014; 9: 252–259.
DOI: 10.4103/1673-5374.128217.
Kim H, Hong MK, Choi H, Moon HS, Lee HJ. Chemopreventive effects of korean red
ginseng extract on rat hepatocarcinogenesis. J Cancer. 2015; 6(1): 1-8.
Kim JS, Tanaka H and Shoyama Y. Immunoquantitative analysis for berberine and its
related compounds using monoclonal antibody in herbal medicines. Analyst. 2004;
129(1): 87–91.
Kim SE, Lee YH, Park JH, Lee SK. Ginsenoside-Rs4, a new type of ginseng saponin
concurrently induces apoptosis and selectively elevates protein levels of p53 and
p21WAF1 in human hepatoma SK-HEP-1 cells. Eur J Cancer, 1999; 35(3): 507-511.
Kim SJ, Kwak HJ, Kim DS, Cho HM, Sim JE, Kim SH, Um JY, Hong SH. Protective
mechanism of Korean Red Ginseng in cisplatin-induced ototoxicity through
attenuation of nuclear factor-kappaB and caspase-1 activation. Mol Med Rep, 2015;
12(1): 315-322.
Kim YJ, Chung JW, Lee SJ, Choi KS, Kim JH, Hahm KB. Progression from chronic
atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng. J
Clin Biochem Nutr. 2010; 46(3): 195-204.
Kim YJ, Jeon JN, Jang MG, Oh JY, Kwon WS, Jung SK, Yang DC. Ginsenoside profiles
and related gene expression during foliation in Panax ginseng Meyer. J Ginseng Res.
2014; 38(1): 66–72.
Kwon ST, Uto T, Morinaga O, Tung HN, Tanaka H, Yuan CS, Shoyama Y. A new strategy
of immunostaining for identification of ginsenosides. Int J Biomed Pharm Sci. 2012;
6: 101-105.
Kwon SW, Han SB, Park IH, Kim JM, Park MK, Park JH. Liquid chromatographic
determination of less polar ginsenosides in processed ginseng. J Chromatogr A. 2001;
921(2): 335-339.
Lee SA, Jo HK, Im BO, Kim S, Wang WK, Ko SK. Changes in the contents of
prosapogenin in the red ginseng (Panax ginseng) depending on steaming batches. J
Ginseng Res. 2012; 36(1): 102-106.
Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance
in A;zjeoer disease. Alzheimer Dis Assoc Disord. 2008; 22: 222-226.
Lee TF, Shiao YJ, Chen CF, Wang LC. Effect of Ginseng Saponins on Beta-Amyloid Suppressed
Acetylcholine Release from Rat Hippocampal Slices. Planta Med. 2001;
67: 634–637. DOI: 10.1055/s-2001-17366.
Lee TK, Johnke RM, Allison RR. Radioprotective potential of ginseng. J. Mutagenesis.
2005; 20(4): 237-243.
Lee YJ, Jin YR, Lim WC, Park WK, Cho JY, Jang S. Ginsenoside-Rb1 acts as a weak
phytoestrogen in MCF-7 human breast cancer cells. Arch Pharm Res. 2003; 26(1): 58-63.
Leggett S, Koczwara B, Miller M. The impact of complementary and alternative medicines
on cancer symptoms, treatment side effects, quality of life, and survival in women
with breast cancer-a systematic review. Nutr Cancer. 2015; 67(3): 373-391.
Leung KW, Cheung LW, Pon YL, Wong RNS, Mak NK, Fan TPD, Au SCL, Tombran Tink J, Wong AST.
Ginsenoside Rb1 inhibits tube-like structure formation of
endothelial cells by regulating pigment epithelium-derived factor through the
oestrogen beta receptor. Br J Pharmacol. 2007; 152(2): 207-215.
Leung KW, Wong AST. Pharmacology of ginsenosides: a literature review. Chin Med.
2010; 5; 20-35.
Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces
apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of
p53. Cancer Lett. 2011; 301(2): 185-192.
Li XY, Liang J, Tang YB, Zhou JG, Guan YY. Ginsenoside Rd Prevents Glutamate Induced
Apoptosis in Rat Cortical Neurons. Clin. Exp. Pharmacol. Physiol. 2010; 37:
199–204. DOI: 10.1111/j.1440-1681.2009.05286.x.
Li Y, Guan Y, Wang Y, Yu CL, Zhai FG, Guan, LX. (2017a). Neuroprotective Effect of
the Ginsenoside Rg1 on Cerebral Ischemic Injury In Vivo and In Vitro Is Mediated by
PPARγ-Regulated Antioxidative and Anti-inflammatory Pathways. Evid. Based
Complement. Altern. Med. 2017, 7842082, DOI: 10.1155/2017/7842082.
Lim JH, Wen TC, Matsuda S, Tanaka J, Maeda N, Peng H, Aburaya J, Ishihara K, Sakanaka
M. (1997). Protection of Ischemic Hippocampal Neurons by Ginsenoside Rb1, a Main
Ingredient of Ginseng Root. Neurosci. Res. 28, 191–200.
DOI: 10.1016/s0168-0102(97)00041-2.
Limsuwanchote S, Wungsintawekul J, Yusakul G, Han JY, Sasaki-Tabata K, Tanaka H,
Shoyama Y, Morimoto S. Preparation of a monoclonal antibody against
notoginsenoside R1, a distinctive saponin from Panax notoginseng, and its application
to indirect competitive ELISA. Planta Med. 2014;80(4):1–6.
Lin Y, Jiang D, Li Y, Han X, Yu D, Park JH, Jin YH. Effect of sun ginseng potentiation on
epirubicin and paclitaxel-induced apoptosis in human cervical cancer cells. J. Ginseng
Res. 2015; 39(1): 22-28.
Liu A, ZhuW, Sun L, Han G, Liu H, Chen Z, Zhuang L, Jiang W, Xue X. Ginsenoside Rb1
Administration Attenuates Focal Cerebral Ischemic Reperfusion Injury through
Inhibition of HMGB1 and Inflammation Signals. Exp Ther Med. 2018;16: 3020–3026.
DOI: 10.3892/etm.2018.6523.
Loungratana P, Tanaka H, Shoyama Y. Production of monoclonal antibody against gingolic
acids in Ginkgo biloba Linn. Am J Chin Med. 2004; 32(1): 33–48.
Lu Z, Morinaga O, Tanaka H, Shoyama Y. A quantitative ELISA using monoclonal
antibody to survey paeoniflorin and albiflorin in crude drugs and traditional Chinese
herbal medicines. Biol Pharm Bull. 2007; 26(6):862–866.
Mehendale S, Aung H, Wang A, Yin JJ, Wang CZ, Xie JT, Yuan CS. American ginseng
berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats [J].
Cancer Chemother Pharmacol. 2005; 56(1): 63-69.
Mehendale SR, Aung HH, Yin JJ, Lin E, Fishbein A, Wang CZ, Xie JT, Yuan CS. Effects
of antioxidant herbs on chemotherapy-induced nausea and vomiting in a rat-pica
model. Am J Chin Med. 2004; 32(6): 897-905.
Mo XQ, Xiao M, Liong X. Identification of ginsenosides in Panax quinquefolium by LC MS.
Chromato. 2006; 64: 31-36.
Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki K, Tonooka S, Samukawa K, Azuma
I. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)-
and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull. 1995; 18(9): 1197-1202.
Morinaga O, Tanaka H and Shoyama Y. Production of monoclonal antibody against a major
purgative component, sennoside A, its characterization and ELISA. Analyst. 2000;
125(6): 1109–1113.
Morinaga O, Tanaka H, Shoyama Y. Detection and quantification of ginsenoside Re in
ginseng samples by a chromatographic immunostaining method using monoclonal
antibody against ginsenoside Re. J Chromatography B. 2006; 830 (1): 100–104.
Nabel EG. CDKs, CKIs: molecular targets for tissue remodelling. Nat Rev Drug Discov.
2002; 1(8): 587-598.
National Institute of Public Health (2015). MHLW grants SYST Em [in Japanese].
NIDD00.Do?resrchNum=201405037A. Available at:
(Accessed June 10, 2020).
Ochiai T, Ohno S, Soeda S, Tanaka H, Shoyama Y, Shimeno H. Crocin prevents the death
of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of
α-tocopherol. Neurosci Lett. 2004; 362(1): 61–64.
Oleszek W and Bialy Z. Chromatographic determination of plant saponins-An update
(2002–2005). J Chromatog A. 2006; 1112: 78-91.
Park HM, Kim SJ, Kim JS, Kang HS.Reactive oxygen species mediated ginsenoside Rg3-
and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling
pathways. Food Chem Toxicol. 2012; 50(8): 2736-2741.
Puetz TW, Morley CA and Herring MP. Effects of creative arts therapies on psychological
symptoms and quality of life in patients with cancer.
JAMA Intern Med. 2013; 173(11): 960-969.
Putalun W, Tanaka H, Shoyama Y. Rapid separation of solasodine glycoside by an
immunoaffinity column using anti-solamargine monoclonal antibody.
Cytotechnology. 1999; 31:151–156.
Qi LW, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges.
Nat Prod Rep 2011; 28(3):467-495.
Quan K, Liu Q, Wan JY, Zhao YZ, Guo RZ, Alolga RN, Li P, Qi LW. Rapid preparation
of rare ginsenosides by acid transformation and their structure-activity relationships
against cancer cells. Sci Rep. 2015; 5: 8598.
Ratan ZA, Haidere MF, Hong YH, Park S, Lee JO, Lee J, Cho JY. Pharmacological
Potential of Ginseng and its Major Component Ginsenosides.
J. Ginseng Res. 2021; 45: 199–210.
Ren G, Zhang XW, Chen F. Predicting color kinetics during red Asian ginseng (Panax
ginseng) preparation. Pharmazie. 2000; 55(4): 300-302.
Rhee MY, Cho B, Kim KI, Kim J, Kim MK, Lee EK, Kim HJ, Kim CH. Blood pressure
lowering effect of Korea ginseng derived ginseol K-g1 [J]. Am J Chin Med. 2014;
42(3): 605-618.
Richardson MA, Straus SE. Complementary and alternative medicine: opportunities and
challenges for cancer management and research. Semin Oncol. 2002; 29(6): 531-545.
Rudakewich M, Ba F, Benishin CG. Neurotrophic and Neuroprotective Actions of
Ginsenosides Rb(1) and Rg(1). Planta Med. 2001; 67: 533–537. DOI: 10.1055/s-2001-16488.
Sakata R, Shoyama Y, Murakami H. Production of monoclonal antibodies and enzyme
immunoassy for typical adenylate cyclase activater, forskolin.
Cytotechnology. 1994; 16(2): 101–108.
Sasaki Y, Shimizu K, Watanabe H, Shoyama Y. Application of Monoclonal Antibody
against Ginsenoside in Ginseng Research: a Review. Tradit Med Res. 2021; 6: 33.
DOI: 10.12032/TMR2021011821510.53388/tmr2021011821.
Sawada J, Janejai N, Nagamatsu K, Terao T. Production and characterization of high affinity
monoclonal antibodies against morphine. Mol Immunol. 1988; 25(9): 937–943.
Seto SW, Chang D, Ko WM, Zhou X, Kiat H, Bensoussan A, Lee SMY, Hoi MPM, Steiner
GZ, Kiu J. Sailuotong Prevents Hydrogen Peroxide (H₂O₂)-Induced Injury in
EA.hy926 Cells. 2017. Int. J. Mol. Sci. 2017; 5,18(1): 95, 2017.
DOI: 10.3390/ijms18010095.
Shan SJ, Tanaka H, Shoyama Y. Enzyme-linked immunosorbent assay for glycyrrhizin
using anti-glycyrrhizin monoclonal antibody and a new eastern blotting for
glucronides of glycyrrhetinic acid. Anal Chem. 2001;73(24):5784–5790.
Shao ZH, Xie JT, Hoek TLV, Mehendale S, Aung H, Li CQ, Qin Y, Schumacker PT,
Becker LB, Yuan CS. Antioxidant effects of American ginseng berry extract in
cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta. 2004;
1670(3): 165-171.
Shen L, Zhang J. Ginsenoside Rg1 Increases Ischemia-Induced Cell Proliferation and
Survival in the Dentate Gyrus of Adult Gerbils. Neurosci. Lett. 2003; 44: 1–4.
DOI: 10.1016/s0304-3940(03)00318-5.
Shergis JL, Zhang AL, Zhou W, Xue CC. Quality and risk of bias in Panax ginseng
randomized controlled trials: a review. Am J Chin Med. 2013; 41(2): 231-252.
Shibata S, Ando T, Tanaka O, Meguro Y, Soma K, Iida Y. Saponins and sapogenins of
Panax ginseng C.A. Meyer and some other Panax spp. Yakugaku Zasshi. 1965; 85: 753–755.
Shibata S, Tanaka O, Nagai M, Ishii T. Studies on the constituents of Japanese and Chinese
crude drugs. XII. Panaxadiol, a sapogenin of ginseng roots. Chem Pharm Bull. 1963;
11: 762–765. DOI: 10.1248/cpb.11.762.
Shibata S, Tanaka O, Soma K, Ando T, Iida Y, Nakamura H. Studies on saponins and
sapogenins of ginseng. The structure of panaxatriol. Tetrahedron Lett. 1965; 42: 207–213.
Shoyama Y, Fukada T, Murakami H. Production of monoclonal antibodies and ELISA for
thebaine and codeine. Cytotechnology. 1996; 19(1): 55–61.
Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015; 65(1): 5-29.
Soeda S, Ochiai T, Shimeno H, Saito H, Abe K, Tanaka H, Shoyama Y. Pharmacological
activities of crocin in saffron. J Nat Med. 2007; 61(2):102–111.
Steiner GZ, Bensoussan A, Liu J, Hohenberg MI, Chang DH. Study protocol for a
randomised, double blind, placebo-controlled 12-week pilot phase II trial of
Sailuotong (SLT) for cognitive function in older adults with mild cognitive
impairment. Trials. 2018:19, 522.
Steiner GZ, Yeung A, Liu JX, Camfield DA, de Blasio FM, Pipingas A, Scholey AB,
Stough C, Chang DH. The effect of Sailuotong (SLT) on neurocognitive and
cardiovascular function in healthy adults: a randomised, double-blind, placebo
controlled crossover pilot trial. BMC Complement Altern Med. 2016; 13, 16:15.
DOI: 10.1186/s12906-016-0989-0.
Sticher O, Solidati F. HPLC separation and quantitative determination of ginsenosides from
Panax ginseng, Panax quinquefolium and from ginseng drug preparations.
Planta Med. 1979; 36: 30-42.
Sun S, Qi LW, Du GJ, Mehendale SR, Wang CZ, Yuan CS. Red notoginseng: higher
ginsenoside content and stronger anticancer potential than Asian and American
ginseng. Food Chem. 2011; 125(4): 1299-1305.
Tanaka H, Fukuda N, Shoyama Y. Eastern blotting and immunoaffinity concentration using
monoclonal antibody for ginseng saponins in the field of traditional Chinese
medicines. J Agr Food Chem. 2007; 55(10): 3783–3787.
Tanaka H, Fukuda N, Shoyama Y. Formation of monoclonal antibody against a major
ginseng component, ginsenoside Rg1 and its characterization.
Cytotechnology. 2000; 34: 197-204.
Tanaka H, Fukuda N, Shoyama Y. Formation of monoclonal antibody against a major
ginseng component, ginsenoside Rb1 and its characterization.
Cytotechnology. 1999; 29(2): 115–120.
Tanaka H, Fukuda N, Yahara S, Isoda S, Yuan CS, Shoyama Y. Isolation of ginsenoside
Rb1 from Kalopanax pictus by eastern blotting using anti-ginsenoside Rb1
monoclonal antibody. Phytother Res. 2005; 19: 255–258.
Tanaka H, Goto Y, Shoyama Y. Monoclonal antibody based enzyme immunoassay for
marihuan (cannabinoid) compounds. Immunoassay. 1996; 17(4): 321–342.
Tanaka H, Putalun W, De-Eknamkul W, Matangkasombut O, Shoyama Y. Preparation of
a novel monoclonal antibody against the antimalarial drugs, artemisinin and
artesunate. Planta Med. 2007; 73(10): 1127–1132.
Tanaka O. Saponin composition of Panax species. In: Shibata S, Ohtsuka Y, Saito H, (Eds.)
Recent Advances in Ginseng Studies, Hirokawa Publishing Co., Tokyo, 1989; pp 43-47.
Tung NH, Shoyama Y. Eastern blotting analysis and isolation of two new dammarane-type
saponins from American ginseng. Chem Pharm Bull. 2012; 60(10): 1329–1333.
Tung NH, Song GY, Woo SH. Ginsenosides from the leaves and flower buds of Panax
ginseng and their pharmacological effects. Current Bioact Comp. 2012; 8(2): 159–166.
Uto T, Tuvshintogtokh I, Shoyama Y. Preparation of knockout extract for determination of
really active compound using MAb. Curr Drug Discov Technol. 2011; 8(1): 16–23.
Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. Red American
ginseng: ginsenoside constituents and antiproliferative activities of heat-processed
Panax quinquefolius roots. Planta Med. 2007; 73(7): 669-674.
Wang CZ, Aung HH, Zhang B, Sun S, Li XL, He H, Xie JT, He TC, Du W, Yuan CS.
Chemopreventive effects of heat-processed Panax quinquefolius root on human breast
cancer cells. Anticancer Res. 2008; 28(5A): 2545-2551.
Wang CZ, Li B, Wen XD, Zhang Z, Yu C, Calway TD, He TC, Du W, Yuan CS. Paraptosis
and NF-kappaB activation are associated with protopanaxadiol-induced cancer
chemoprevention. BMC Complement Altern Med. 2013; 13: 2.
Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals: active
constituents and their potential role in cardiovascular illness.
Am J Chin Med. 2007; 35(4): 543-558.
Wang CZ, Ni M, Sun S, Li XL, He H, Mehendale SR, Yuan CS. Detection of adulteration
of notoginseng root extract with other panax species by quantitative HPLC coupled
with PCA [J]. J Agric Food Chem, 2009, 57(6): 2363-2367.
Wang CZ, Zhang B, Song WX, Wang A, Ni M, Luo X, Aung HH, Xie JT, Tong R, He TC,
Yuan CS. Steamed American ginseng berry: ginsenoside analyses and anticancer
activities. J Agric Food Chem. 2006; 54(26): 9936-9942.
Wang CZ, Zhang Z, Anderson S, Yuan CS. Natural products and chemotherapeutic agents
on cancer: prevention vs. treatment. Am J Chin Med. 2014; 42(6): 1555-1558.
Wang CZ, Zhang Z, Wan JY, Zhang CF, Anderson S, He X, Yu C, He TC, Qi LW, Yuan
CS. Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects
of fluorouracil on colon cancer. Nutrients. 2015; 7(2): 799-814.
Wang KY, Liu WC, Zhang MP, Zhao MZ, Wang YF, Li L, Sun CY, Hu KX, Cong YY,
Wang Y. Expression of saponin biosynthesis related genes in different tissues of Panax
quinquefolius. China J Chin Mater Medica. 2018; 43(1): 65–71.
Wang XQ, Cheng FF, Qu HH, Zhao Y, Yu C, Liu YJ. New perspectives on specific
immune-depletion technique using monoclonal antibodies against small active
molecules in herbs. Evid Based Complement Alternat Med. 2014; 2014: 393680.
Weiler EW. Chemistry of Plant Protection. Berlin: Springer-Verlag;1990.
Wu Y, Lindblad JL, Garnett J, Kaya HEK, Xu D, Zhao Y, Flores ER, Hardy J, Bergmann
A. Genetic characterization of two gain-of-function alleles of the effector caspase
DrICE in Drosophila. Cell Death Different. 2016; 23: 723–732.
DOI: 10.1038/cdd.2015.144.
Wu Y, Lu X, Xiang FL, Lui EMK, Feng Q. North American ginseng protects the heart from
ischemia and reperfusion injury via upregulation of endothelial nitric oxide synthase.
Pharmacol Res. 2011; 64(3): 195-202.
Xuan L, Tanaka H, Xu Y, Shoyama Y. Preparation of monoclonal antibody against crocin
and its characterization. Cytotechnology. 1999; 29(1): 65–70.
Yamaguchi H, Kasai R, Matsuura H, Tanaka O, Fuwa T. High performance liquid
chromatography analysis of acidic saponins of ginseng and related plants.
Chem Pharm Bull. 1988; 36: 3468-3473.
Yamaguchi Y, Higashi M, Kobayashi H. Effects of Ginsenosides on Impaired Performance
Caused by Scopolamine in Rats. Eur J Pharmacol. 1996; 312: 149–151.
DOI: 10.1016/0014-2999(96)00597-3.
Yan X, Zhao Y, Zhang Y, Qu H. Monoclonal antibodies and immunoassay for medical
plant-derived natural products: a review. Molecules. 2017; 22(3): 839.
Yanagihara H, Sakata R, Minami H, Tanaka H, Shoyama Y, Murakami H. Immunoaffinity
column chromatography against forskolin using an anti-forskolin monoclonal
antibody and its application. Anal Chim Acta. 1996; 335: 63–70.
Yang WZ, Hu Y, Wu WY, Ye M, Guo DA. Saponins in the genus Panax L. (Araliaceae):
a systematic review of their chemical diversity. Phytochemistry. 2014; 106: 7-24.
Yin J, Zhang D, Zhuang J, Huang Y, Mu Y, Lv S. Study on the correlation between gene
expression and enzyme activity of seven key enzymes and ginsenoside content in
ginseng in over time in Ji’an, China Int J Mol Sci. 2017; 18(12): 2682.
Yokota S, Onohara Y, Shoyama Y. Immunofluorescence and imunoelectron microscopic
localization of medicinal substance, Rb1, in several plant parts of Panax ginseng.
Current Drug Discov Tech. 2011; 8(1): 51–59.
Yuan CS, Wang CZ, Wicks SM, Qi LW. Chemical and pharmacological studies of saponins
with a focus on American ginseng. J Ginseng Res. 2010; 34(3): 160-167.
Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S er al. Brief communication:
American ginseng reduces warfarin’s effect in healthy patients: a randomized,
controlled Trial. Ann Intern Med. 2004; 141(1): 23-27.
Yue PYK, Wong DYL, Wu PK, Leung PY, Mak NK, Yeung HW, Liu L, Cai Z, Jiang ZH,
Fan TPD, Wong RNS. The angiosuppressive effects of 20(R)- ginsenoside Rg3.
Biochem Pharmacol, 2006; 72(4): 437-445.
Yun TK and Choi SY. A case-control study of ginseng intake and cancer [J]. Int J
Epidemiol, 1990, 19(4): 871-876.
Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a
case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev.
1995; 4(4): 401-408.
Yun TK, Lee YS, Lee YH, Kim SI, Yun HY. Anticarcinogenic effect of Panax ginseng
C.A. Meyer and identification of active compounds. J Korean Med Sci. 2001; 16
Suppl: S6-18.
Yun TK. Experimental and epidemiological evidence on non-organ specific cancer
preventive effect of Korean ginseng and identification of active compounds.
Mutat Res. 2003; 523-524: 63-74.
Yun TK. Experimental and epidemiological evidence on non-organ specific cancer
preventive effect of Korean ginseng and identification of active compounds.
Mutat Res. 2003; 523-524: 63-74.
Yun TK. Panax ginseng-a non-organ-specific cancer preventive.
Lancet Oncol. 2001; 2(1): 49-55.
Zhang B, Matsuda S, Tanaka J, Tateishi N, Maeda N, Wen TC, Peng H, Sakanaka M.
Ginsenoside Rb(1) Prevents Image Navigation Disability, Cortical Infarction, and
Thalamic Degeneration in Rats with Focal Cerebral Ischemia. J. Stroke Cerebrovasc.
Dis. 1998; 7: 1–9. DOI: 10.1016/s1052-3057(98) 80015-3.
Zhang C, Du F, Shi M, Ye R, Cheng H, Han J, Ma L, Cao R, Rao Z, Zhao G. Ginsenoside
Rd Protects Neurons against Glutamate-Induced Excitotoxicity by Inhibiting Ca(2+)
Influx. Cell Mol Neurobiol. 2012; 32: 121–128. DOI: 10.1007/s10571-011-9742-x.
Zhang G, Liu A, Zhou Y, San X, Jin T, Jin Y. Panax Ginseng Ginsenoside-Rg2 Protects
Memory Impairment via Anti-apoptosis in a Rat Model with Vascular Dementia. J.
Ethnopharmacol. 2008; 115: 441–448. DOI: 10.1016/ j.jep.2007.10.026.
Zhang HN, Zhao YY, Liang H, Liang H, Huang LQ, Zhang ZX. Simultaneous HPLC ELSD determination
of saikosaponins a, c, d, f in Radix Bupleuri. Chin J Pharm Anal.
2007; 27(8): 1150–1153.
Zhang X, Shi M, Bjørås M, Wang W, Zhang G, Han J, Liu Z, Zhang Y, Wang B, Chen J,
Zhu Y, Xiong L, Zhao G. Ginsenoside Rd Promotes Glutamate Clearance by Up Regulating
Glial Glutamate Transporter GLT-1 via PI3K/AKT and ERK1/2 Pathways.
Front. Pharmacol. 2013; 4: 152. DOI: 10.3389/fphar.2013.00152.
Zhang YL, Zhang R, Xu HL, Yu XF, Qu SC, Sui DY. 20(S)-protopanaxadiol triggers
mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via
inhibiting the PI3K/Akt signaling pathway. Am J Chin Med, 2013; 41(5): 1137-1152.
Zhang Z, Li Z, Wu X, Zhang CF, Calway T, He TC, Du W, Chen J, Wang CZ, Yuan CS.
TRAIL pathway is associated with inhibition of colon cancer by protopanaxadiol.
J Pharmacol Sci. 2015; 127(1): 83-91.
Zhao YN, Shao X, Ouyang LF, Chen L, Gu Ling. Qualitative detection of ginsenosides in
brain tissues after oral administration of high-purity ginseng total saponins b using
polyclonal antibody against ginsenosides. Chin J Nat Med. 2018; 16(3):175–183.
Zheng T, Jiang H, Jin R, Zhao Y, Bai Y, Xu H, Chen Y. Ginsenoside Rg1 Attenuates
Protein Aggregation and Inflammatory Response Following Cerebral Ischemia and
Reperfusion Injury. Eur J Pharmacol. 2019; 853: 65–73.
DOI: 10.1016/j.ejphar.2019.02.018.
Zhou B, Wang J, Yan Z. Ginsenoside Rg3 attenuates hepatoma VEGF overexpression after
hepatic artery embolization in an orthotopic transplantation hepatocellular carcinoma
rat model. Onco Targets Ther. 2014; 7: 1945-1954.
Zhu J, Jiang Y, Wu L, Lu T, Xu G, Liu X. Suppression of Local Inflammation Contributes
to the Neuroprotective Effect of Ginsenoside Rb1 in Rats with Cerebral Ischemia.
Neuroscience. 2012; 202: 342–351. DOI: 10.1016/j. neuroscience.2011.11.070.
Zhu SH, Shimokawa S, Tanaka H, Shoyama Y. 2004. Development of an assay system for
saikosaponin a using anti-saikosaponin a monoclonal antibodies. Biol Pharm Bull.
2004; 27(1): 66–71.


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!